SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients

Cell Mol Immunol. 2021 Aug;18(8):2040-2041. doi: 10.1038/s41423-021-00730-8. Epub 2021 Jul 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • Female
  • Humans
  • Immunity, Cellular*
  • Immunogenicity, Vaccine*
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / virology
  • Vaccination
  • Vaccines, Inactivated / administration & dosage
  • Young Adult

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Vaccines, Inactivated